Ling Maria K, Hotta Eri, Kilianova Zuzana, Haitina Tatjana, Ringholm Aneta, Johansson Lisa, Gallo-Payet Nicole, Takeuchi Sakae, Schiöth Helgi B
Department of Neuroscience, Uppsala University, BMC, Box 593, 751 24 Uppsala, Sweden.
Br J Pharmacol. 2004 Nov;143(5):626-37. doi: 10.1038/sj.bjp.0705900. Epub 2004 Oct 4.
1 Melanocortin (MC) receptors are widely distributed throughout the body of chicken, like in mammals, and participate in a wide range of physiological functions. 2 To clarify the pharmacological impact of ligands acting in the MC system, we expressed the chicken MC1, MC2, MC3, MC4 and MC5 (cMC1-5) receptors in eukaryotic cells and performed comprehensive pharmacological characterization of the potency of endogenous and synthetic melanocortin peptides. 3 Remarkably, the cMC receptors displayed high affinity for ACTH-derived peptides and in general low affinity for alpha-MSH. It is evident that not only the cMC2 receptor but also the other cMC receptors interact with ACTH-derived peptide through an epitope beyond the sequence of alpha-MSH. 4 The synthetic ligand MTII was found to be a potent agonist whereas HS024 was a potent antagonist at the cMC4 receptor, indicating that these ligands are suitable for physiological studies in chicken. 5 We also show the presence of prohormone convertase 1 (PC1) and PC2 genes in chicken, and that these peptides are coexpressed with proopiomelanocortin (POMC) in various tissues.